Scientists uncover new clues about fatty liver inflammation
NCT ID NCT02820285
First seen Apr 08, 2026 · Last updated May 16, 2026 · Updated 3 times
Summary
This study looked at special proteins called immune semaphorins in people with fatty liver disease and NASH. The goal was to learn how these proteins might control inflammation in the liver and fat tissue. Researchers studied 148 obese patients to find new markers or future treatment targets.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-ALCOHOLIC FATTY LIVER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Service d'Hépato-Gastroentérologie - Hôpital de l'Archet
Nice, 06003, France
Conditions
Explore the condition pages connected to this study.